UT Southwestern Home

Research Technician II, Grow Lab job at UT Southwestern Medical Center, Dallas, TX

https://jobs.utsouthwestern.edu/job/22051222/research-technician-ii-grow-lab/

Discover Research Technician II, Grow Lab and other Research & Laboratory jobs in Dallas, TX and apply online today!

Tenure-track Faculty Opportunity job at UT Southwestern Medical Center, Dallas, TX

https://jobs.utsouthwestern.edu/job/22055456/tenure-track-faculty-opportunity-dallas-tx/

Discover Tenure-track Faculty Opportunity and other Faculty and Physicians jobs in Dallas, TX and apply online today!

airc-2010a-symposium.pdf

https://www.utsouthwestern.edu/edumedia/edufiles/departments_centers/airc/airc-2010a-symposium.pdf

Presented by The Advanced Imaging Research Center and The National Center for Research Resources in association with UT Southwestern Medical Center Program Objective Since Warburg’s discoveries in the 1920s, physicians and scientists have known that metabolism in cancer is different from normal tissue because of the intense metabolic demands for cell proliferation. More recently, it has been shown with molecular methods that metabolic disorders may in some instances cause cancer

Advanced Practice Provider, Pediatric Nephrology job at UT Southwestern Medical Center, Dallas, TX

https://jobs.utsouthwestern.edu/job/21606062/advanced-practice-provider-pediatric-nephrology/

Discover Advanced Practice Provider, Pediatric Nephrology and other Advanced Practice Provider jobs in Dallas, TX and apply online today!

ADC-fall-2012-newsletter.pdf

https://www.utsouthwestern.edu/edumedia/edufiles/departments_centers/neurology/alzheimers_disease_center/ADC-fall-2012-newsletter.pdf

Scientists have made remarkable advances toward developing effec- tive therapies for Alzheimer’s disease in the past year. There is a broad consensus now that amyloid and its most toxic form, Aß42, is directly responsible in part for the dementia of Alzheimer’s disease. Researchers in Iceland associated with the company deCODE Genetics have just reported that a rare muta- tion in the amyloid gene is sufficient to impair the conversion of the less toxic form of amyloid to its more

Microsoft Word - Document1

https://www.utsouthwestern.edu/edumedia/edufiles/departments_centers/mineral_metab_ctr/reducing-stone-risk.pdf

Short Title Reducing Stone Risk in Topamax‐treated Patients Study Number 112006‐045 Study Title Comparison of potassium citrate and citric acid supplementation for modification of stone risk profile, and assessment of calcium metabolism and bone turnover in topiramate‐treated subjects Disease/Condition Under Study Kidney Stones/Osteoporosis Brief Description of Study 1‐month crossover study with potassium citrate and citric acid. The study will require 4 outpatient visits

STARD_FG_V3 (34447 - Activated,

https://www.utsouthwestern.edu/edumedia/edufiles/departments_centers/depression/vitalsign6/measures/fibser-with-scoring.pdf

FIBSER - Frequency and Intensity of Burden of Side Effects Rating INSTRUCTIONS: Select the best response for the following three questions. 1. Choose the response that best describes the frequency (how often) of the side effects of the medication you have taken within the past week for your depression. Do not rate side effects if you believe they are due to treatments that you are taking for medical conditions other than depression. Rate the frequency of these side effects for the past week